Augmedix, Inc. announced that William Febbo has joined its board of directors, effective March 28, 2022. He is currently Chief Executive Officer and Director of OptimizeRx. Mr. Febbo previously served as Chief Operating Officer of Investment Banking at Merriman Capital and Chief Executive Officer of Digital Capital Network.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9181 USD | -8.14% | -19.46% | -84.31% |
05-29 | Augmedix Appoints Alex Stinard as Chief Clinical AI Officer | CI |
05-14 | Maxim Downgrades Augmedix to Hold From Buy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.31% | 44.96M | |
+12.50% | 68.79B | |
+7.35% | 17.45B | |
+20.68% | 13.58B | |
+8.66% | 13.35B | |
+12.48% | 9.8B | |
-20.94% | 6.74B | |
-4.74% | 5.95B | |
+2.67% | 5.23B | |
-3.21% | 4.85B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Augmedix, Inc. Names William Febbo as New Member to its Board of Directors